Alzheimer's disease is type 3 diabetes-evidence reviewed. - Test2 - elhamkhani - TriplyDB

Alzheimer's disease is type 3 diabetes-evidence reviewed.

Alzheimer's disease is type 3 diabetes-evidence reviewed.

http://www.wikidata.org/entity/Q34020000

about

Dietary interventions for maintaining cognitive function in cognitively healthy people in late life Dietary interventions for prevention of dementia in people with mild cognitive impairment Food reward, hyperphagia, and obesity Neuropharmacological review of the nootropic herb Bacopa monnieri Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal The impact of hippocampal lesions on trace-eyeblink conditioning and forebrain-cerebellar interactions Evaluating the Association between Diabetes, Cognitive Decline and Dementia Type 2 diabetes and cognitive impairment: linking mechanisms A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art Food reward functions as affected by obesity and bariatric surgery Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System Amylin at the interface between metabolic and neurodegenerative disorders Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer's disease?Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model Finding needles in a haystack: application of network analysis and target enrichment studies for the identification of potential anti-diabetic phytochemicals Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease Imaging in pancreatic disease.Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols.Ceramide-mediated insulin resistance and impairment of cognitive-motor functions Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease.Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.Resting-state functional MR imaging shed insights into the brain of diabetes.Machine Learning and Data Mining Methods in Diabetes Research Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1 Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Type 2 diabetes and quality of life.Insulin, cognition, and dementia Meta Analysis of Human AlzGene Database: Benefits and Limitations of Using C. elegans for the Study of Alzheimer's Disease and Co-morbid Conditions Bio-informatics analysis of a gene co-expression module in adipose tissue containing the diet-responsive gene Nnat.Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.

P2860

Q24186820-422D8714-060A-4EE8-8359-DA7D480CB208 Q24186832-52C52107-B72A-4C6A-9EEA-E4B3F617E94B Q24609658-D99E87C0-BE1F-401B-AC14-A21E8E62D55E Q24630774-8761E220-E3C9-47CC-8E2E-4281F8F78A06 Q26382049-D595B31E-8B78-4717-A65A-B4ED7E655A96 Q26783344-A69BB7F1-5B8D-461E-A10E-96BC8F3F0FF0 Q26799293-60BE0881-65E4-4EB6-8637-34435F3824CF Q26801774-DCCA83B8-D1BB-4DAD-9AD6-269D2C9C7AB1 Q26822993-DC275D04-8225-46D5-A5E4-869A3FDDFCFF Q26827439-BC022ADF-262C-42D1-83BA-138311A66F16 Q26830845-BFBA2254-B562-429A-A70A-0950B78AC0AB Q26861264-FB1DD509-3C4B-4431-AD6D-84E70D23B0DD Q26866392-92F6A8CE-5A3E-4222-A497-EBE7018B8118 Q26999386-068C5033-1C89-4C77-B649-287873DC57AE Q27003342-DEA4546D-AE9F-490F-B6BB-CBB866DF65E1 Q27011370-CEDDC626-F505-4B3A-A3B8-F23D9F48A7A8 Q27694676-1F7CBB29-1BD3-4895-848D-B4F8D0D1E946 Q28077589-0ABB344B-AA9A-4087-9D2B-6D8C5BA590D2 Q28079442-7321BA07-388A-4230-A2AA-8D0BC9AAF6F8 Q28543427-A7AF555C-9A88-46BF-9091-F7B7E622C2AD Q28544976-460991A2-6554-4128-9831-B1926509E75F Q28553200-C6C872C0-B9A4-4AB9-ABF6-DB7D1643DEC9 Q28731520-457776D4-145E-41DA-AE54-287BCB154CA9 Q30275458-78288DF4-F171-4738-A1D0-A8725D2BC1A3 Q30415477-C296DBB5-AAAA-438F-B706-444A77686202 Q30478907-8870224E-AC56-4EDA-BFFF-50A2D6C84E8F Q30479198-6E480F26-6561-42B6-B53C-75D9650700AC Q30484122-BB3EC6DE-37A4-49BB-B7CB-5849D52981E6 Q31047629-9E69EB12-EC3C-4EC7-A5F9-3A02DD05703C Q31108663-B6772D6F-2BDA-4F12-9994-DBEB82F79DC9 Q31109560-001A2A0C-6038-460E-8B03-AF19D06E706F Q31117440-F85894E2-1EE6-49B7-B538-2752563E2EEB Q31157922-D333B02D-28FB-4FE9-AF8B-BF726CABFC4F Q33362745-C53C34CD-621A-4E30-B0CB-F97E0A6BF8CB Q33543381-87C21A5A-91CA-42AA-8E8D-C165C52ABDC4 Q33573159-5F1DF2FF-F9CE-481B-AAAA-ECBD932BF4F7 Q33604874-20CE60D7-B022-4933-8247-B96FA1D8E4CD Q33665362-8D75B6DE-16AA-4B97-8335-80103A310602 Q33780753-4B802F34-246C-4CD6-8F31-24DE0945B0E0 Q33789329-439262D4-C2DA-4997-8F89-0D1D37C88B00

P2860

Alzheimer's disease is type 3 diabetes-evidence reviewed.

http://www.wikidata.org/entity/Q34020000

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@ast

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@en

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@nl

type

label

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@ast

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@en

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@nl

prefLabel

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@ast

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@en

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@nl

P1433

Q34020000-749BE340-FB1C-46DC-A61D-DE55966FDA22

P1476

Q34020000-6DFBCA9E-DD13-49D1-9354-1A5334726296

P2093

Q34020000-2FA89140-B7C4-4CD3-99BF-923900B1F834

Q34020000-C4C23160-DE88-4D25-BD33-864A42CE6B66

P2860

Q34020000-0039CD44-666C-4458-AA0F-92761AB0EBD9

Q34020000-004D9DDA-FC7A-423E-A659-24D05C3626FF

Q34020000-08B465B6-E12B-49F1-918C-3EE9FC129B2B

Q34020000-099903F4-15ED-4122-B042-D43EEDD4036B

Q34020000-0C9545C9-5515-4A80-BA9F-AA50CBD1D3FD

Q34020000-0CAA43A3-E72F-47A4-BACE-84627D8D395C

Q34020000-0E44314D-60D2-412E-A1CB-B3D76A908A62

Q34020000-109352E0-FE3F-46CE-9243-38F5E739F475

Q34020000-1207EA82-C95B-4329-9329-8304A859E85A

Q34020000-128110B7-B1B5-4F41-A900-417401ED19EA

P304

Q34020000-DB9D9A90-A271-4C0A-B32F-AD203177EB4D

P31

Q34020000-0D678B45-ADDE-4569-835F-703D9399A8F2

P356

Q34020000-C398AD48-6212-4146-A1D1-E815A0C3DB1A

P433

Q34020000-969567CB-CB93-49D9-9877-DD1564EEAE90

P478

Q34020000-39DCDB67-EBBD-4B30-BB4D-669906DC6892

P577

Q34020000-CF6FA2B6-B355-40E8-BECC-3B5B58086D4B

P5875

Q34020000-CB5FBB9F-BDDA-45C6-99B6-DC894B7280D9

P698

Q34020000-BDBC942B-1879-463B-9944-F5D1A9978119

P921

Q34020000-172C0D47-45A9-499E-B4E5-0A4B84D33EF8

P932

Q34020000-6D399438-85D6-40B1-BF6F-39ABE59C6AEF

P356

193229680800200619

P1433

Journal of Diabetes Science and Technology

P1476

Alzheimer's disease is type 3 diabetes-evidence reviewed.

@en

P2093

Jack R Wands

http://www.w3.org/2001/XMLSchema#string

Suzanne M de la Monte

http://www.w3.org/2001/XMLSchema#string

P2860

Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1

Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation

Genotoxicity of streptozotocin

The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas

Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase.

Regulation of neuronal survival by the serine-threonine protein kinase Akt

P304

1101-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/193229680800200619

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38063363

http://www.w3.org/2001/XMLSchema#string

P698

19885299

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2769828

http://www.w3.org/2001/XMLSchema#string